NL-OMON51805尚未招募4 期
Prospective Analysis of Pharmacokinetic Infliximab data in Paediatric Inflammatory Bowel Disease patients - PRO-RAPID
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 15（—）
入选标准
- •Diagnosed with Crohn's disease, age 1-15, anti-TNF naive, indication to start
排除标准
- •Established monogenetic disease, perianal/fistulizing disease, severe
- •comorbidity (not related to IBD)
研究者
相似试验
尚未招募
4 期
Pro-RAPIDCrohn's Disease2023-507352-72-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)50
进行中（未招募）
1 期
Prospective Analysis of Pharmacokinetic Infliximab data in Paediatric Inflammatory Bowel Disease patients (Pro-RAPID)Crohn's DiseaseCTIS2023-507352-72-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)50
进行中（未招募）
不适用
The degradation and elimination of InfliximabInflammatory bowel disease (Ulcerative Colitis, Crohn's disease)MedDRA version: 17.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 17.0Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-001332-29-ATniversitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie
已完成
不适用
Study of the pharmacokinetics of Infliximab (IFX) in moderate to severe Ulcerative ColitisInflammatory Bowel Disease10017969Ulcerative ColitisNL-OMON37516Academisch Medisch Centrum20
已完成
不适用
Prediction of therapeutic efficacy of infliximab for refractory ulcerative colitis by analyzing and measuring serum concentration of cytokines and infliximabJPRN-UMIN000010205School of Medicine, Keio University Division Gastroenterology and Hepatology, Department of Internal Medicine100